Seattle, Washington
United States
20
2024-03-14
The entities that hold a legal rights for patent applications filed by inventor Lieber Andre:
Andre Lieber from Seattle, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor
#2 | 2023-10-19METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PROGENITOR CELLS IN VIVO
#3 | 2023-10-05INTEGRATION OF LARGE ADENOVIRUS PAYLOADS
#4 | 2023-05-04CONDITIONING REGIMENS FOR IN VIVO GENE THERAPY
#5 | 2022-12-01BASE EDITOR-MEDIATED CD33 REDUCTION TO SELECTIVELY PROTECT THERAPEUTIC CELLS
#6 | 2022-08-18RECOMBINANT AD35 VECTORS AND RELATED GENE THERAPY IMPROVEMENTS
#7 | 2022-07-21DETECTION OF DESMOGLEIN-2 IN CANCERS OF EPITHELIAL ORIGIN
#8 | 2022-04-28Desmoglein 2 (DSG2) binding proteins and uses therefor
#9 | 2020-09-03Desmoglein 2 (DSG2) binding proteins and uses therefor
#10 | 2019-03-28Desmoglein 2 (DSG2) binding proteins and uses therefor
#11 | 2017-08-31Desmoglein 2 (DSG2) binding proteins and uses therefor
#12 | 2017-02-09In vivo Gene Engineering with Adenoviral Vectors
#13 | 2016-09-08Desmoglein 2 (DSG2) binding proteins and uses therefor
#14 | 2015-09-03Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor
#15 | 2014-04-17Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
#16 | 2011-12-15Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
#17 | 2010-10-07Compositions and methods for modulating the activity of complement regulatory proteins on target cells
#18 | 2006-12-14Capsid-modified adenovirus vectors and methods of using the same
#19 | 2006-08-22Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
#20 | 2006-04-06Adenovirus vectors for immunotherapy
728609 ⎘